Bosh sahifaPTX • ASX
add
Prescient Therapeutics Ltd
Yopilish kursi
0,084 $
Kunlik diapazon
0,083 $ - 0,085 $
Yillik diapazon
0,038 $ - 0,13 $
Bozor kapitalizatsiyasi
91,64 mln AUD
Oʻrtacha hajm
3,28 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
ASX
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (AUD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,55 mln | 75,34% |
Joriy xarajat | 4,02 mln | 61,47% |
Sof foyda | -2,44 mln | -5,52% |
Sof foyda marjasi | -156,80 | 39,82% |
Har bir ulushga tushum | — | — |
EBITDA | -2,46 mln | -53,80% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (AUD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 6,93 mln | -52,27% |
Jami aktivlari | 14,56 mln | -28,59% |
Jami passivlari | 3,17 mln | 36,50% |
Umumiy kapital | 11,39 mln | — |
Tarqatilgan aksiyalar | 805,32 mln | — |
Narxi/balansdagi bahosi | 8,40 | — |
Aktivlardan daromad | -42,27% | — |
Kapitaldan daromad | -54,05% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (AUD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -2,44 mln | -5,52% |
Operatsiyalardan naqd pul | -727,11 ming | 62,84% |
Sarmoyadan naqd pul | 1,00 mln | -75,00% |
Moliyadan naqd pul | -17,14 ming | — |
Naqd pulning sof oʻzgarishi | 260,74 ming | -87,20% |
Boʻsh pul | -1,38 mln | -43,48% |
Haqida
Prescient Therapeutics Ltd is a clinical stage oncology company. The company is focused on the development of a universal CAR-T platform, enhanced CAR-T cell manufacturing & function and on two small molecule drug targeted therapies. Wikipedia
Tashkil etilgan
22-may, 1986
Xodimlar soni
3
